
Altole IV 40mg Injection
Marketer
Altius Life Sciences
Salt Composition
Pantoprazole (40mg)
Overview Altole IV 40mg Injection
Gastric acid production is reduced by the intravenous administration of 40mg Proacid IV Injection. This medication treats stomach and intestinal disorders stemming from excess acid, including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, alleviating symptoms and promoting healing. Proacid IV 40mg is also prophylactic against stress ulcers in critically ill patients and is pre-anesthetically administered to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this injection is intravenously delivered by a medical professional only when deemed superior to oral medication. Dosage is condition- and response-dependent, determined by your physician, and should continue as prescribed, irrespective of symptom resolution. Optimizing treatment involves consuming smaller, more frequent meals and avoiding caffeine, spicy, and fatty foods. Common, typically mild, side effects encompass nausea, vomiting, headache, dizziness, flatulence, diarrhea, abdominal pain, and thrombophlebitis (venous inflammation). Persistent or bothersome side effects necessitate medical attention. Prolonged use, especially exceeding one year, elevates the fracture risk, particularly at higher doses. Discuss bone loss (osteoporosis) prevention strategies, such as calcium and vitamin D supplementation, with your doctor. Proacid IV 40mg is contraindicated for individuals with severe hepatic impairment, those on HIV medications, those with a history of similar medication allergies, or pre-existing osteoporosis. Pregnant or lactating individuals should seek medical advice before use. Alcohol consumption, exacerbating acid production, should be avoided. Refrain from operating machinery if dizziness or drowsiness occurs.
Uses of Altole IV 40mg Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Altole IV 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Altole IV 40mg Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Altole IV 40mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Altole IV 40mg Injection works:
Gastric acid secretion is diminished by the proton pump inhibitor Altole IV 40mg Injection, thereby alleviating heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Altole IV 40mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Altole IV 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Administration of Altole IV 40mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Altole IV 40mg Injection on driving ability is undetermined. Refrain from driving if you exhibit any symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Intravenous Altole 40mg is considered safe for administration to individuals with impaired renal function. No alteration of the Altole 40mg IV dosage is necessary.
LiverCAUTION
Intravenous Altole, 40mg, requires careful administration in individuals with significant hepatic impairment. Dosage modification for Altole 40mg IV injection may be necessary. Physician consultation is advised.
What if you forget to take Altole IV 40mg Injection :
Omit a scheduled Altole IV 40mg Injection? Seek your physician's advice.
Facts to Know About Altole IV 40mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
| Active Class | PPIs (proton pump inhibitors) |
